Drug Delivery Systems Market Size & Share, by Type (Transdermal, Inhalation, Injectable); Device Type (Conventional, Advanced); Indication (Diabetes, Cardiovascular Disease, Multiple Sclerosis, Asthma COPD); Distribution Channel (Hospital Pharmacy, Retail Pharmacy) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 4460
  • Published Date: Aug 25, 2023
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2023 - 2035

Drug Delivery Systems Market size is anticipated to surpass USD 433 billion by the end of 2035, growing at a CAGR of 11% during the forecast period i.e., 2023 – 2035. In the year 2022, the industry size of drug delivery system was USD 42 billion. The growth of this market can be attributed to the increased availability of vaccines for different types of diseases such as typhoid, tuberculosis, influenza, hepatitis, and others. According to a report, in 2021 the global coverage of hepatitis B is around 80% for Haemophilus influenza type B vaccine nearly 71% and nearly 80% of infants all over the world received polio vaccination.

The cases of chronic disease are constantly rising owing to lifestyle disorders, unhealthy eating habits, and sleeping disorders. According to the World Health Organization, about 17.9 million people die of cardiovascular disease every year, and cardiovascular is the primary reason for most of the deaths in the world.


Drug Delivery Systems Market
Get more information on this report: Request Free Sample PDF

Drug Delivery System Sector: Growth Drivers and Challenges

Growth Drivers

  • Technological Advancement and Innovations in Drug Delivery Systems- The rising development in technology has always favored market growth such as microneedle arrays are a new technology for delivering medications through the skin. In these arrays, several microscopic needles, each thinner than a strand of hair, are coated or filled with medicine. Therefore, technological advancement in drug delivery systems is anticipated to boost the market's growth in the upcoming years. Such as, Medtronic announced the release of Efficio, an advanced cloud-based data management technology application for use with SynchroMed II intramedullary drug delivery system in January 2020.
  • Rapid COVID-19 Vaccination Drive all over the World- There has been a rising demand for syringes owing to increasing COVID-19 vaccinations across the globe. Moreover, it has boosted the production of injectable drug delivery, and it is projected to drive the market's growth. According to the reported data, globally, 3.87 million vaccinations are done every day, and 12.69 billion doses have been given worldwide.
  • Growth of Digital Drug Delivery- The rising popularity and importance of digital drug delivery among companies is expected to increase the growth of the global drug delivery systems market. Nearly 60% of people working at a company size of 5000 believe that digital drug delivery technology is crucial.

Challenges

  • Strict Rules and Regulations Set by the Government - The government has imposed strict mandates to be followed while checking the product in order to ensure the efficacy and safety of the product. These stringent rules and regulations might limit the production of a new product or any other development of an old product. Therefore, the factor is likely to hamper the market growth.
  • Negative Impact and Data Security Risk Associated with Drug Delivery System
  • Customer Trust is Compromised Owing to the Invasive Nature of Drug Delivery

Drug Delivery Systems Market: Key Insights

Base Year

2022

Forecast Year

2023 – 2035

CAGR

~11%

Base Year Market Size (2022)

~USD 42 billion

Forecast Year Market Size (2035)

~USD 433 billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Drug Delivery System Segmentation

Indication (Diabetes, Cardiovascular Disease, Multiple Sclerosis, Asthma COPD)

Drug delivery systems market from the diabetes market is anticipated to expand and register the highest CAGR of 33% over the coming years. The increasing number of diabetes patients worldwide may be attributed to the segment's expansion. According to the World Health Organisation, there are 422 million diabetics worldwide. Moreover, the high utilization of insulin injections by diabetes patients is also expected to boost the growth of this segment in the projected period.

Type (Transdermal, Inhalation, Injectable)

The injectable sector is anticipated to see the most market growth over the next years. This is attributable to individuals becoming more aware of wearable injectable medicine delivery methods. Furthermore, it is anticipated that segmental expansion will be aided in the coming years by the expanding immunization campaign that is increasing syringe usage globally. Also it is anticipated that until vaccines are completed, the growing need for needles and syringes will fuel segmental expansion.

Our in-depth analysis of the global market includes the following segments:

 

   Type

  • Transdermal
  • Inhalation
  • Injectable

 

   Device Type

  • Conventional
  • Advanced

 

 

   Indication

  • Diabetes
  • Cardiovascular Disease
  • Multiple Sclerosis
  • Asthma COPD

 

   Distribution Channel

  • Hospital Pharmacy
  •  Retail Pharmacy

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Drug Delivery Industry- Regional Synopsis

North America Market Forecasts

By the end of 2035, the North American drug delivery systems market is anticipated to have the greatest revenue share of 35% worldwide. Longer hospital stays in the area are likely to fuel the market expansion for drug delivery systems in North America during the anticipated time frame. According to a paper published in April 2021, Canada experienced approximately 3 million acute inpatient hospitalizations in the years 2019–2020. The region's delivery systems are expected to improve as a result of these hospitalizations.

Europe Market Statistics  

On the other side, Europe is anticipated to maintain a sizable market share during the projection period. This is explained by the region's growing recognition of cutting-edge medication delivery methods and acceptance of cutting-edge technology. The launch of novel medication delivery systems by important stakeholders is also projected to fuel regional market expansion, as are clinical studies for crucial governance permissions for innovative medicines.

Research Nester
Drug Delivery Systems Market size
Get more information on this report: Request Free Sample PDF

Companies Dominating the Drug Delivery System Landscape

top-features-companies
    • BD (Becton, Dickinson, and Company)
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Gerreshelmer AG
    • Baxter
    • Nemara
    • Kindeva Drug Delivery
    • West Pharmaceutical Services Inc.
    • Ypsomed
    • Medtronic Inc.
    • E3D Elcam Drug Delivery Devices
    • Astra Zeneca
    • Merck KGaA

In the News

  • Nemara announced the sponsorship of Celie Gross for their latest launch Wearable Injectors of On Drug Delivery. The product is designed to suffice the unmet drug delivery needs in chronic diseases. The lack of simultaneous response to the challenges related to biologics, self-administration, connectivity, and sustainability in one device is a driving force behind the thought that it would be good for patients who suffer from chronic disease to have an intelligent, sustainable on-body injector.
  • Merck KGaA announces a collaboration with InnoCore Pharmaceuticals to provide Innocare with the proprietary SynBiosys biodegradable polymer platform. It is a drug delivery platform developed to reduce the hurdles in injectable formulation. This collaboration will enable new and potentially life-changing drugs to be made available, by creating a prolonged release of protein therapeutic products into the market. By reducing dosing frequency and maintaining medicines at therapeutic levels for longer, it will also improve patient compliance.

Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 4460
  • Published Date: Aug 25, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The growing digital drug delivery and increasing prevalence of chronic diseases are some of the major factors anticipated to drive the growth of the drug delivery system market.

The market is anticipated to attain a CAGR of ~11% over the forecast period, i.e., 2023 – 2035.

The major players in the market are Gerreshelmer AG, Baxter, Nemara, Kindeva Drug Delivery, West Pharmaceutical Services Inc., Ypsomed, Medtronic Inc., E3D Elcam Drug Delivery Devices, Astra Zeneca, Merck KGaA, and others.

The diabetes segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.

The market in North America is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.
Drug Delivery Systems Market Report Scope
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying